RSV, maternal vaccine, RSV monoclonal antibodies, effectiveness, nirsevimab, children, hospitalisation, infant
Invasive aspergillosis, Epidemiology, outcome, Australasia
SARS-CoV-2, covid-19, serosurvey, Qualitative, children, paediatric research